Senti Biosciences, Inc.SNTINASDAQ

Revenue (LTM)

-100.0% YoY

Net Income (LTM)

$-53M

+25.7% YoY

Free Cash Flow

$-41M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	2↑481.5%	3↑43.4%	2↓39.8%	0
Gross Profit	0	2↑481.5%	3↑43.4%	2↓39.8%	0
Operating Income	-25	-40↓63.8%	-62↓53.5%	-93↓49.4%	-61↑34.2%
Net Income	-20	-55↓178.5%	-58↓5.2%	-71↓22.1%	-53↑25.7%
EBITDA	-23	-37↓64.9%	-58↓55.4%	-61↓5.5%	-55↑10.5%
EPS Diluted	-4.55	-12.67↓178.5%	-13.25↓4.6%	-20.94↓58.0%	-11.49↑45.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	31	56↑83.5%	58↑2.8%	36↓37.7%	48↑34.4%
Total Current Assets	32	59↑85.3%	103↑74.6%	71↓30.6%	59↓17.2%
Total Assets	48	97↑100.0%	181↑87.0%	119↓33.9%	98↓18.1%
Total Current Liabilities	5	15↑198.9%	18↑24.1%	13↓29.8%	13↑3.7%
Total Liabilities	107	36↓66.1%	54↑47.4%	53↓1.8%	72↑37.3%
Total Equity	-59	60↑202.8%	127↑110.8%	67↓47.4%	26↓61.7%
Total Debt	14	23↑61.8%	37↑63.2%	38↑1.6%	34↓10.7%
Net Debt	-16	-33↓102.0%	-21↑38.4%	2↑108.5%	-15↓941.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-24	-35↓43.3%	-35↓0.8%	-52↓50.1%	-41↑21.0%
Capital Expenditure	-1	-6↓377.4%	-41↓646.4%	-12↑70.9%	-0↑99.8%
Free Cash Flow	-25	-40↓58.6%	-76↓89.8%	-64↑15.5%	-41↑35.7%
Stock-Based Comp	0	2↑743.8%	16↑614.2%	10↓41.0%	2↓81.9%
Net Change in Cash	25	28↑12.0%	2↓94.0%	-22↓1370.0%	12↑157.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance